1. Expediting drug development—the FDA's new ‘breakthrough therapy’ designation;Sherman;N Engl J Med,2013
2. Reflection paper on a proposal to enhance early dialogue to facilitate accelerated assessment of priority medicines (PRIME);Eur Med Agency,2015
3. Oncology 2020: a drug development and approval paradigm;Dhingra;Ann Oncol,2015
4. Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary. Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation. Washington, DC: National Academies Press, 2010.
5. Participation in cancer clinical trials: race-, sex-, and age-based disparities;Murthy;JAMA,2004